Chronic tic disorder in children and adolescents
Chronic tic disorders including Tourette syndrome are neurodevelopmental disorders affecting 0.5-1% of children and adolescents. The disorders are characterised by the occurrence of motor and/ or vocal tics. The course of the tic disorder may be very fluctuating both in intensity, symptom presentation and localisation. [1] [2] [3] [4] Behavioural and psychosocial interventions are recommended as the primary treatment in children and adolescents 5 where therapeutic treatments include habit reversal training (HRT) and exposure response prevention (ERP). 5 Habit reversal training and exposure response prevention in tic treatment
The treatment effect of HRT 6 has been examined in several randomised controlled trials showing a significant reduction of tic intensity both as a total score with effect sizes of 0.68, 7 0.57 8 and 1.50, 9 and as a reduction in tic severity, as measured by the Yale Global Tic Severity Scale (YGTSS) 10 of 37.5%, 11 Furthermore, a significant reduction has been shown for separate scores for motor and vocal symptoms, and impairment (effect sizes of 0.49 (motor), 0.50 (vocal) and 0.57 (impairment)). 7, 8 A single randomised controlled trial examined the effect of ERP 12 compared with HRT. 13 Effect sizes of 1.42 and 1.06 were found for ERP and HR, respectively. No difference could be found between HRT and ERP. 13 In an open randomised controlled clinical trial, Nissen et al 14 examined the effectiveness of a treatment manual combining HRT and ERP delivered in an individual and a group setting. The study showed a significant reduction in total tic severity (TTS) score with an effect size of 1.26 and in functional impairment score (as measured by the YGTSS) with an effect size of 1.41. Apart from the functional impairment score, there was no difference between the individual setting and group therapy. 14 
Predictors and moderators in tic treatment
To optimise treatment outcome, an understanding of predictors and moderators of treatment outcome could prove important.
In a study from 2017, Sukhodolsky et al 15 examined predictors on treatment response following Comprehensive Behavioural Intervention for Tics (CBIT) or supportive therapy. They demonstrated that a higher tic severity at baseline and positive expectations of treatment predicted a greater tic improvement following CBIT, whereas anxiety disorders and premonitory urge severity predicted a lower tic reduction. 15 Other studies have not been able to establish a relation between premonitory urges and tic inhibition. 16 In a sample of both children and adults, McGuire et al showed that different clusters of tic symptoms did not predict treatment response, and they concluded that therapeutic treatment with CBIT/HRT was effective over a range of tic types. 17 Sukhodolsky et al also examined moderators of treatment response. 15 They showed that tic medication moderated treatment response, where tic reduction following CBIT was unaffected by tic medication, whereas medication was associated with a greater tic reduction after supportive therapy. Other psychiatric disorders such as attention-deficit hyperactivity disorder, obsessive-compulsive disorder or anxiety disorders, age, gender, family functioning, symptom characteristics or treatment expectancy did not moderate treatment response. 15 In a study by Houghton et al, 18 habituation was examined as the process leading to tic reduction mediated through a decrease in premonitory urge severity. Reductions in premonitory urge could not be proved to moderate treatment outcome, thus questioning the role of habituation in therapeutic treatment procedures. In conclusion, the knowledge on predictors for therapeutic treatment outcome is scarce in children and adolescents. The most convincing factors, however, seem to be tic severity at baseline, the magnitude of premonitory urge, expectations for treatment and the occurrence of anxiety disorders.
Tic severity in childhood is an important predictor for future quality of life as rated in adults. 19 Therefore, the availability of an effective treatment for childhood tic disorders is important. Previously, we have described a significant positive outcome of treatment in individual as well as in group settings.
14 The aim of the present study was to examine possible predictors of treatment outcome in an open randomised controlled clinical trial examining the effectiveness of a combined treatment of HRT and ERP in children and adolescents with chronic tic disorders. The study focused on predictors and mediators for treatment outcome after an acute therapeutic intervention in all participants. Furthermore, the study examined moderators for treatment outcome in groups compared with individual treatment.
Method
The open randomised controlled clinical trial is described elsewhere. 14 In brief, children and adolescents referred to the specialised Tourette out-patient clinic at the Department of Child and Adolescent Psychiatry, Aarhus University Hospital, Psychiatry, Denmark, and diagnosed with a chronic tic disorder were randomised to manualised treatment including HRT and ERP delivered either as individual training or training in groups of four. The treatment for both the individual and group setting was based on a newly designed manual 20 describing an eight-session treatment plus a booster session. During the sessions, the participants were trained in both HRT and ERP. In the individual therapy, the parents participated in the last 15 min of each session, whereas in the group setting the parents participated at the end of the second, fourth, eighth and ninth session.
14 The therapy was conducted by a trained and supervised psychologist, a child and adolescent psychiatrist, and a teacher.
The study was approved by the National Ethical Committee (1-10-72-216-15) and the Danish Data Protection Agency (1-16-02-490-15), registered 12 October 2015. Oral and written information was given to parents and patients, and written consent from patients over 15 years and parents were received.
Diagnostic eligibility was established using a modified version of the Schedule for Affective Disorders and Schizophrenia for SchoolAge Children -Present and Lifetime version (K-SADS-PL) 21 administered to the parent and child/adolescent separately. The K-SADS-PL information was used to confirm a primary diagnosis of chronic tic disorder and to ensure that none of the exclusion criteria were met. Exclusion criteria included symptoms or disorders that required immediate treatment. Thus, patients with psychotic disorders, severe depression, suicidal ideation or attempts and severe anorexia nervosa were excluded. Furthermore, children and adolescents with an IQ below 70, a lifetime diagnosis of pervasive developmental disorder, or treatment with HRT or ERP during the past 6 months were excluded. If sufficient treatment was offered for the comorbid primary condition, or if medication for tics or other psychiatric disorders was stable, the patients were included in the treatment study.
14 At baseline and at the eighth session, the participants completed Screen for Child Anxiety Related Emotional Disorders (SCARED), 22 the Mood and Feelings Questionnaire (MFQ) 23 the Premonitory Urge Scale (PUTS) 24 and Beliefs About Tics Scale (BATS). 25 The parents completed SCARED, the MFQ, Child Behaviour Checklist (CBCL), 26 and the Sensory Profile, 27 where the parents were asked about their child's sensitivity during childhood and adolescence. 14 The main outcome measures were TTS (motor score + vocal score) and functional impairment as evaluated by YGTSS, and a positive responder status, defined as a more than 25% reduction in severity scores. 28 Evaluations of treatment response were made by an independent evaluator who was not masked to the treatment allocation, yet not involved in the treatment of the patient and masked to any previous evaluations. The evaluators were a specialised psychologist and a child and adolescent psychiatrist with several years of experience in diagnosing, evaluating and treating tic disorders. A random sample of 18 patients was audiotaped (10%) and evaluated by another rater with extensive experience and expertise in the use of the YGTSS. The analysis revealed that the intraclass correlation coefficient was 0.88 (95% CI 0.72-0.95) for TTS (motor and vocal tics) and 0.89 (95% CI 0.74-0.95) for functional impairment. 14 
Predictor and moderator variables
Predictors are characteristics affecting response regardless of treatment assignment. Based on a recent study, 15 we selected the following baseline variables as potential predictors of treatment outcome: age, gender, tic severity at baseline (YGTSS TTS and functional impairment scores), the magnitude of premonitory urge (PUTS), expectations of treatment (Likert scale: how much do you believe in the treatment 0-4) and the occurrence of comorbid symptoms or disorders (modified KSADS, CBCL, SCARED, MFQ). Since hypersensitivity may be associated with premonitory urge, Sensory Profile scores were included in the analyses. In a study by Leclerc et al, 29 it was shown that a cognitive and psychophysiological programme with focus on processes influencing thoughts and behaviours underlying tics had a positive effect on tic severity and improved self-esteem post-treatment. Therefore, the present study also examined the effect of basic beliefs evaluated using the BATS. The same baseline variables were examined as moderators that could influence differential response to individual therapy compared with group therapy. Changes in the PUTS score (PUTS diff ) and BATS score (BATS diff ) (baseline -post-treatment) were correlated to treatment outcome.
Statistics
The associations between baseline characteristics and outcome measures after eight treatment sessions were expressed as mean differences using linear regression analysis. Similarly, the associations between baseline characteristics and responder rate were expressed as risk difference using binary regression.
The correlation between the change in BATS or PUTS and outcome measures were further analysed in a multiple linear regression analysis. We similarly performed correlation analysis for the responder rate using binary regression.
The moderation of difference in treatment outcome between individual and group setting by baseline characteristics were examined in a multiple linear regression analysis by including an interaction between the treatment type and the baseline characteristics.
Nissen et al
We similarly performed a moderator analysis for the responder rate using binary regression.
A P < 0.05 was considered statistically significant. Given the exploratory nature of the moderator and predictor analysis, the study did not correct for multiple comparisons.
Results

Characteristics of the participants
A total of 102 children and adolescents were screened and 59 (mean age 12.24 years, 9-17 years; males n = 37 (62.7%)) were randomly assigned to either individual treatment (n = 31, mean age 12.30 years), or treatment in a group setting (n = 28, mean age 12.18 years). A total of 54 children and adolescents participated throughout the study (individual setting n = 27; group setting n = 27).
Predictors for treatment outcome for the whole group
Baseline anxiety scores (SCARED scores) evaluated by the parents predicted a significantly lesser decrease in functional impairment scores (functional impairment diff ) (SCARED parent mean difference −0.21 (95% CI −0.37 to −0.04), P = 0.017) ( Table 1) . Age predicted a larger decrease in functional impairment (mean difference 2.30 (95% CI 1.3-3.3), P = 0.001).
The occurrence of obsessive-compulsive symptoms predicted a larger reduction in the change in TTS (mean difference 4.24 (95% CI 0.33-8.14), P = 0.034). Furthermore, baseline TTS predicted a larger TTS at eighth session (mean difference 0.41 (95% CI 0.18-0.64), P = 0.001). However, a greater baseline severity also predicted a greater reduction from baseline to eighth session (mean difference 0.59 (95% CI 0.36-0.82), P = 0.001). When the TTS at baseline was dichotomised into moderate severity (YGTSS TTS ≤ 29) or marked severity (YGTSS TTS > 29), marked severity predicted a significantly lower end score at eighth session (mean difference −0.95 (95% CI −1.88 to −0.03), P = 0.04). This was different for lower severity scores (mean difference 0.56 (95% CI 0.24-0.88), P = 0.001). Baseline functional impairment did not predict the end score at eighth session (mean difference 0.19 (95% CI −0.05 to 0.43), P = 0.12). However, a greater baseline severity predicted a greater functional difference reduction from baseline to eighth session (mean difference 0.81 (95% CI 0.57-1.05), P = 0.001) There was a trend that an increased sensitivity to noises and sounds was associated with an increased functional impairment at eighth session mean difference 3.19 (95% CI −0.58 to 6.96), P = 0.10) (data not shown).
Predictor of achieving responder status
A positive responder status was defined as a reduction of more than 25% in severity score. 28 Responder status was independent of CBCL scores, age, gender, comorbidity and baseline severity ( Table 1) .
Correlation between change in BATS and PUTS scores and change in TTS and functional impairment As shown in Table 2 , there was a significant correlation between changes in BATS scores from baseline to the eighth session (BATS diff ) and the reduction in functional impairment score (functional impairment diff ) (mean difference 0.43 (95% CI 0.17-0.69), P = 0.002). Comparably, after correcting for baseline functional impairment score, there was an inverse correlation between the BATS diff and functional impairment at eighth session (mean difference −0.27 (95% CI −0.46 to −0.09), P = 0.005). There was no correlation between BATS diff and change in TTS (TTS diff ) or responder rates. There was no correlation between the changes of PUTS score from baseline to post-treatment (PUTS diff ) and functional impairment diff or TTS diff . However, after correcting for baseline functional impairment score, there was an inverse correlation between the PUTS diff score and functional impairment at eighth session (mean difference −0.32 (mean difference −0.63 to −0.02), P = 0.038).
Moderators for individual versus group treatment outcome
See Table 3 (and supplementary Fig. 1a-f , available at https://doi. org/10.1192/bjo.2019.56). In relation to functional impairment scores, the presence of hypersensitivity and high scores on the Table 1 The associations as mean difference or risk difference between each baseline variable and treatment outcome measured as change in total tic severity (TTS) score (TTS diff ) , change in functional impairment score (functional impairment diff ) and responder rate TTS diff , mean difference (95% CI) P MFQ (both parents' and children's evaluation) and on the CBCL favoured individual treatment. If the child was not diagnosed with anxiety, individual therapy showed the most favourable outcome. High baseline PUTS scores moderated TTS at the eighth session and responder rate favouring group therapy. In contrast, but comparable with functional impairment high scores of MFQ (parent) favoured individual treatment.
Discussion
Main findings
The present study examined predictors and moderators of treatment outcome in children and adolescents diagnosed with a chronic tic disorder and treated with a combination of HRT and ERP. The study showed that internalising disorders (anxiety) predicted a lesser reduction in functional impairment, whereas TTS score at baseline predicted severity at post-treatment. Furthermore, beliefs about the tic symptoms were shown to have a negative influence on treatment outcome, and several baseline characteristics such as anxiety, a high score on premonitory urge, baseline sensitivity and a high score on the MFQ could moderate treatment outcome depending on the therapeutic setting. To our knowledge, this is the first study examining factors predicting and moderating perceived functional impairment following a therapeutic intervention. The study adds to the knowledge on predictors and moderators for treatment outcome evaluated by TTS score. Furthermore, this is the first study examining the predicting and moderating effect of a child's belief about their tic symptoms as measured by the BATS questionnaire.
Interpretation of our findings
The predictor analysis identified a few variables that affected posttreatment outcome regardless of treatment assignment. High scores on parental ratings of the child's anxiety predicted a lesser decrease in functional impairment scores (functional impairment diff ).
Occurrence of comorbid symptoms such as anxiety may influence treatment outcome and not least the way the child perceives the impairment related to the tic disorder. Sukhodolsky et al 15 also showed that co-occurring anxiety disorders were associated with less tic reduction after treatment. They proposed incorporation of more active anxiety and stress management strategies. 15 The results from the present study support these considerations and emphasise the importance of identifying the occurrence of anxiety and depressive symptoms.
Increased age predicted an increased reduction in the perceived impairment. Thus, adolescents may experience an even better effect on their general well-being and function. Several of the participants rated increased feeling of control as even more important than the reduction in tic symptoms. 14 This increased feeling of control may be very important in the socially active lives of the adolescents.
Participants with greater baseline severity of motor and vocal tics experienced a higher end score of motor and vocal tic severity. However, dichotomising baseline TTS scores into moderate severity (YGTSS TTS ≤29) or marked severity (YGTSS TTS >29), marked severity predicted a significant lower end score at eighth session. Thus, the overall higher end score of motor and vocal tic severity may cover a differential effect of baseline severity scores, supporting that patients with severe tic disorders may benefit from therapeutic interventions. This finding is in accordance with the European recommendation of behavioural and psychosocial intervention as the primary treatment in children and adolescents independent of severity of the tic disorder. 5 The occurrence of obsessive-compulsive symptoms predicted a larger reduction in TTS. Obsessive-compulsive symptoms are closely related to tic symptoms and it may often be difficult to distinguish these symptoms, especially from the complex tics. Likewise, the recommended treatment of obsessive-compulsive symptoms is comparable with tic treatment. Thus, children and adolescents with obsessive-compulsive symptoms may have experienced an effect on both these symptoms and the tics and may have rated both as a reduction in tic symptoms. However, the results emphasise that obsessive-compulsive symptoms are no hindrance to a positive outcome of tic treatment. The severity of premonitory urge did not predict treatment outcome in the present study. This finding is in contrast to the findings of Sukhodolsky et al. 15 However, the PUTS scores showed no significant difference from baseline to the eighth session, 14 which is in accordance with a study from 2013 that showed that urge ratings did not decline during the following prolonged tic suppression. 30 There was a significant positive correlation between the reduction in BATS scores and a decrease in perceived functional impairment. Even though the result does not point to causality, the finding suggests that persistent thoughts may have a negative influence on treatment outcome as measured by the child's experience of general function. Classical behavioural treatment of tics does not include cognitive elements. However, a child's experience of how much the tic symptoms impact on everyday life is dependent on the child's interpretation of the tic symptoms. The BATS questionnaire includes questions on how tics and premonitory urge may affect the child if the child suppresses tics. Thus, a high score on the BATS indicates intense thoughts concerning the necessity to tic as soon as the child feels a bodily sensation. In a study by Leclerc et al, 29 it was shown that a cognitive and psychophysiological programme with focus on processes influencing thoughts and behaviours underlying tics had a positive effect on tic severity and improved self-esteem post-treatment. It could therefore prove important to include a baseline examination of possible thoughts, and to include cognitive elements in the treatment procedures. However, beliefs or thoughts about tic, and perceived functional impairment seem to be dynamic parameters. Since the scores were evaluated at the same time point, a reduction in perceived functional impairment may also have had a positive influence on the child's general thoughts about their tics, including an achieved experience of enhanced control.
The reduction of premonitory urge did not correlate with the change in perceived functional impairment, whereas the reduction was inversely correlated to functional impairment at eighth session. Even though the severity of premonitory urge at baseline did not predict treatment outcome, the course of the premonitory urge during treatment may influence how impaired the child continues to feel despite a reduction in motor and vocal tic severity. As many children and adolescents may not experience habituation to the premonitory urge, it is important that treatment includes teaching about how the child learns to accept and endure the urge feeling.
Individual versus group treatment
Several baseline characteristics moderated treatment outcome differentially to the treatment setting. A high PUTS score, anxiety and a low CBCL score at baseline favoured treatment in groups as evaluated by TTS and functional impairment. In contrast, increased sensitivity at baseline and a high score on the MFQ favoured individual treatment. Thus, the predictor analysis showed that anxiety symptoms predicted a lower treatment outcome, and the moderator analysis further showed that these factors differentially influence the response to individual versus group treatment. Thus, comorbidity may influence treatment outcome in tic treatment, and it may therefore be necessary to incorporate more active treatment modalities focusing on mood and anxiety disorders. A high score on sensitivity favoured individual treatment. Increased sensitivity to external stimulus may be associated with increased sensitivity or increased attention to inner stimulus as well. In an individualised setting, the therapist might have a better opportunity to train endurance of sensitivity along with training of competing response and exposure. A high PUTS score favoured a group setting. Training together with peers may help to endure the premonitory urge and distract the attention from these unpleasant sensations.
Limitations
The results should be considered in the light of limitations. The number of participants is rather low, which is especially important for the moderator analysis. This renders interpretation of the results more difficult. Furthermore, given the exploratory nature of the moderators and predictor analysis, the study did not correct for multiple comparisons. Another important limitation is the lack of masking of the evaluators although the evaluators did not take an active part in the treatment course and they were masked for previous evaluations. Finally, there is no control condition, which may render it difficult to distinguish between predictors specific to active treatment versus to a more general improvement.
Overall, the combined treatment of HRT and ERP in an individual setting or in groups is helpful to reduce tic intensity and perceived impairment in children and adolescents with a chronic tic disorder.
14 However, the present study points towards factors that may influence treatment outcome and that therefore require consideration when choosing supplemental treatment strategies. This applies for the occurrence of comorbid anxiety or depressive symptoms, but also for the child's own belief about their tics and the premonitory urge sensation. Other co-occurring psychiatric conditions or the feeling of not-just-right did not moderate treatment effects. Thus, in spite of these other conditions, the combined treatment delivered both individually and in groups is effective in reducing the overall tic severity and impairment in children and adolescents. 
